glycopyrrolate

Generic: glycopyrrolate

Labeler: athenex pharmaceutical division, llc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name glycopyrrolate
Generic Name glycopyrrolate
Labeler athenex pharmaceutical division, llc.
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

glycopyrrolate .2 mg/mL

Manufacturer
Athenex Pharmaceutical Division, LLC.

Identifiers & Regulatory

Product NDC 70860-781
Product ID 70860-781_2cc9bce0-af74-e52c-e063-6394a90aba8d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210083
Marketing Start 2023-01-31
Marketing End 2026-04-30

Pharmacologic Class

Classes
anticholinergic [epc] cholinergic antagonists [moa] cholinergic muscarinic antagonist [epc] cholinergic muscarinic antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70860781
Hyphenated Format 70860-781

Supplemental Identifiers

RxCUI
238212 1731582 1731590
UNII
V92SO9WP2I

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name glycopyrrolate (source: ndc)
Generic Name glycopyrrolate (source: ndc)
Application Number ANDA210083 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .2 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (70860-781-05) / 5 mL in 1 VIAL (70860-781-43)
source: ndc

Packages (1)

70860-781-05 25 VIAL in 1 CARTON (70860-781-05) / 5 mL in 1 VIAL (70860-781-43)

Ingredients (1)

glycopyrrolate (.2 mg/mL)

Linked Drug Pages (1)

Glycopyrrolate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2cc9bce0-af74-e52c-e063-6394a90aba8d", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["238212", "1731582", "1731590"], "spl_set_id": ["c444d63b-f394-4ae5-a74d-50105a406574"], "manufacturer_name": ["Athenex Pharmaceutical Division, LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (70860-781-05)  / 5 mL in 1 VIAL (70860-781-43)", "package_ndc": "70860-781-05", "marketing_end_date": "20260430", "marketing_start_date": "20230131"}], "brand_name": "Glycopyrrolate", "product_id": "70860-781_2cc9bce0-af74-e52c-e063-6394a90aba8d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "70860-781", "generic_name": "glycopyrrolate", "labeler_name": "Athenex Pharmaceutical Division, LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glycopyrrolate", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA210083", "marketing_category": "ANDA", "marketing_end_date": "20260430", "marketing_start_date": "20230131"}